HEALTHCARE

14 Dec 2017

Pharmaceutical investments in Egypt hit LE120 bln: Official

Head of the Federation of Egyptian Chambers of Commerce Ahmed al Wakil on Tuesday said that the value of pharmaceutical investments in Egypt hit 120 billion pounds.

In his speech at a conference on modernizing"...

Continue Reading

11 Dec 2017

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research"...

Continue Reading

11 Dec 2017

AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials

AstraZeneca and Acerta Pharma, its haematology research and development centre of excellence, today presented results from the Phase Ib/II ACE-CL-003 clinical trial (Abstract #432) and updated results from the Phase I/II ACE-CL-001 (Abstract #498) clinical trial that are testing Calquence"...

Continue Reading

10 Dec 2017

Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti-BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting

Celgene Corporation (NASDAQ: CELG) and bluebird bio, Inc. (Nasdaq: BLUE) today announced that updated results from the ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-cell maturation antigen (BCMA) CAR T cell therapy, in 21 patients with late-stage relapsed/refractory multiple myeloma will be presented in an oral presentation at the American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia. The objective of this Phase 1 dose-escalation study is to evaluate safety and efficacy of bb2121 and determine a recommended Phase 2 dose. “Celgene has a longstanding commitment to patients with multiple myeloma......

Continue Reading

10 Dec 2017

NMC Health Ushers In New Era of Healthcare Innovation at 2017 Milken Institute London Summit

Innovations such as artificial intelligence will enable healthcare providers around the world to offer patients a better level of service, the CEO of the region’s leading healthcare groups, NMC Healthcare, has said at a healthcare conference in London.

Speaking"...

Continue Reading

10 Dec 2017

Emirates Hospital Advances Breast Cancer Care with New Sentimag® Technology

Emirates Hospital, a subsidiary of Emirates Healthcare and located in Dubai, has become the first healthcare facility in the UAE to acquire Sentimag®, an innovative medical device that greatly improves a clinician’s ability to precisely diagnose breast cancer. It also helps the"...

Continue Reading

10 Dec 2017

Mommies Gather for a Meet and Interact Session Held by Cosmesurge

CosmeSurge, a subsidiary of Emirates Healthcare, in association with CPI Media Group held a meet and interact session titled ‘Mother Baby & Child Mama’s Morning’ for seasoned and new mums. Held at Burj Al Arab on December"...

Continue Reading

08 Dec 2017

Neustar Launches Next Generation DDoS Defense Network: SiteProtect NG™

Neustar, Inc., a trusted, neutral provider of real-time information services, today launched SiteProtect NG™ (Next Generation), its new solution to protect brands against DDoS (distributed denial of service) attacks. It is the latest wave of the company’s purpose-built DDoS mitigation solution designed to meet the security requirements of all brands, on-premise and in the cloud, to deal with the next generation of cyber threats. This powerful upgrade adds Neustar’s state of the art WAF (web application firewall) solution to the award-winning Neustar SiteProtect solution to extend network protection to the application layer.......

Continue Reading

05 Dec 2017

UN Voices Alarm Over Up to 40% Rise of HIV Cases in Egypt, Mostly Among Youth

The UN has revealed this unsettling problem in Egypt, which faces a tremendous rise of HIV cases while being hampered by the social stigma over homosexuality.

The UN has raised the alarm over the spread of HIV"...

Continue Reading

04 Dec 2017

Julphar Introduces the Latest Technology in Continuous Glucose Monitoring “Dexcom G5 Mobile” to UAE

As part of its commitment to transforming diabetes care and management by delivering best-in-class solutions, Gulf Pharmaceutical Industries (Julphar) will introduce Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System in a satellite symposium"...

Continue Reading
Found articles: - Pages  
Contact US | Powered by CNPHUB.com - All Rights Reserved